Exact Mass: 233.1739328
Exact Mass Matches: 233.1739328
Found 331 metabolites which its exact mass value is equals to given mass value 233.1739328,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Butam
CONFIDENCE standard compound; INTERNAL_ID 622; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9488; ORIGINAL_PRECURSOR_SCAN_NO 9487 CONFIDENCE standard compound; INTERNAL_ID 622; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9481; ORIGINAL_PRECURSOR_SCAN_NO 9480 CONFIDENCE standard compound; INTERNAL_ID 622; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9496; ORIGINAL_PRECURSOR_SCAN_NO 9495 CONFIDENCE standard compound; INTERNAL_ID 622; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9386; ORIGINAL_PRECURSOR_SCAN_NO 9381 CONFIDENCE standard compound; INTERNAL_ID 622; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9444; ORIGINAL_PRECURSOR_SCAN_NO 9443 CONFIDENCE standard compound; INTERNAL_ID 622; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9430; ORIGINAL_PRECURSOR_SCAN_NO 9429
Methylphenidate
Methylphenidate is only found in individuals that have used or taken this drug. It is a central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of dextroamphetamine. [PubChem]Methylphenidate blocks dopamine uptake in central adrenergic neurons by blocking dopamine transport or carrier proteins. Methylphenidate acts at the brain stem arousal system and the cerebral cortex and causes increased sympathomimetic activity in the central nervous system. Alteration of serotonergic pathways via changes in dopamine transport may result. N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics > N06BA - Centrally acting sympathomimetics D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators
hexahomomethionine
A sulfur-containing amino acid consisting of 2-aminodecanoic acid having a methylthio substituent at the 10-position.
Normeperidine
Pethidine (INN) or meperidine hydrochloride (USAN) (commonly referred to as Demerol in the US but also referred to as: isonipecaine; lidol; pethanol; piridosal; Algil; Alodan; Centralgin; Dispadol; Dolantin; Mialgin (in Indonesia); Petidin Dolargan (in Poland); Dolestine; Dolosal; Dolsin; Mefedina) is a fast-acting opioid analgesic drug. Pethidine is quickly hydrolysed in the liver to pethidinic acid and is also demethylated to norpethidine, which has half the analgesic activity of pethidine but a longer elimination half-life (8-12 hours); accumulating with regular administration, or in renal failure. Norpethidine is toxic and has convulsant and hallucinogenic effects. The toxic effects mediated by the metabolites cannot be countered with opioid receptor antagonists such as naloxone or naltrexone and are probably primarily due to norpethidines anticholinergic activity probably due to its structural similarity to atropine though its pharmacology has not been thoroughly explored. The neurotoxicity of pethidines metabolites is a unique feature of pethidine compared to other opioids. Pethidines metabolites are further conjugated with glucuronic acid and excreted into the urine. D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D002800 - Cholinesterase Inhibitors D004791 - Enzyme Inhibitors
Rotundine B
Rotundine C is found in root vegetables. Rotundine C is an alkaloid from the rhizomes of Cyperus rotundus (nutgrass).
Lysinoalanine
C9H19N3O4 (233.13754939999998)
Nephrotoxic food contaminan
Thalictroidine
Thalictroidine is found in coffee and coffee products. Thalictroidine is an alkaloid from the rhizomes of Caulophyllum thalictroides (blue cohosh Alkaloid from the rhizomes of Caulophyllum thalictroides (blue cohosh). Thalictroidine is found in coffee and coffee products.
Hypusine
Hypusine is formed in eIF-5A by post-translational modification of one of the lysyl residues. There are two reactions and two enzymes involved:; Hypusine is an unusual amino acid found in all eukaryotes and in some archaea, but not in bacteria. The only known protein containing hypusine is eukaryotic translation initiation factor 5A (eIF-5A) and a similar protein found in archaebacteria. In human, two isoforms of eIF-5A have been described: eIF-5A-1 and eIF-5A-2. They are coded by two different genes. This protein is involved in protein biosynthesis and promotes the formation of the first peptide bond. The region surrounding the hypusine residue is highly conserved among the eukaryotes and is essential to the function of eIF-5A. Thus, hypusine and eIF-5A appear to be vital for the viability and proliferation of eukaryotic cells. [HMDB] Hypusine is formed in eIF-5A by post-translational modification of one of the lysyl residues. There are two reactions and two enzymes involved:; Hypusine is an unusual amino acid found in all eukaryotes and in some archaea, but not in bacteria. The only known protein containing hypusine is eukaryotic translation initiation factor 5A (eIF-5A) and a similar protein found in archaebacteria. In human, two isoforms of eIF-5A have been described: eIF-5A-1 and eIF-5A-2. They are coded by two different genes. This protein is involved in protein biosynthesis and promotes the formation of the first peptide bond. The region surrounding the hypusine residue is highly conserved among the eukaryotes and is essential to the function of eIF-5A. Thus, hypusine and eIF-5A appear to be vital for the viability and proliferation of eukaryotic cells.
Seryllysine
C9H19N3O4 (233.13754939999998)
Seryllysine is a dipeptide composed of serine and lysine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Lysylserine
C9H19N3O4 (233.13754939999998)
Lysylserine is a dipeptide composed of lysine and serine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Hydroxypropionylcarnitine
Hydroxypropionylcarnitine is an acylcarnitine. More specifically, it is an hydroxypropionoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Hydroxypropionylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine hydroxypropionylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. It is also decreased in the urine of individuals with obesity (PMID: 26910390) and systolic heart failure (PMID: 26010610). Hydroxypropionylcarnitine can also be found incerebrospinal fluid. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. A human metabolite taken as a putative food compound of mammalian origin [HMDB]
Dexmethylphenidate
Dexmethylphenidate is only found in individuals that have used or taken this drug. It is the dextrorotary form of methylphenidate. It is used for treatment of Attention Deficit Hyperactivity Disorder (ADHD). Methylphenidate blocks dopamine uptake in central adrenergic neurons by blocking dopamine transport or carrier proteins. Methylphenidate acts at the brain stem arousal system and the cerebral cortex and causes increased sympathomimetic activity in the central nervous system.Methylphenidate is a catecholamine reuptake inhibitor that indirectly increases catecholaminergic neurotransmission by inhibiting the dopamine transporter (DAT) and norepinephrine transporter (NET), which are responsible for clearing catecholamines from the synapse, particularly in the striatum and meso-limbic system. N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics > N06BA - Centrally acting sympathomimetics D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators
2-Phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide
C13H17N2O2 (233.12899620000002)
D000975 - Antioxidants > D016166 - Free Radical Scavengers D020011 - Protective Agents > D000975 - Antioxidants
4-[(2,4-Dihydroxy-3,3-dimethylbutanoyl)amino]butanoic acid
D002491 - Central Nervous System Agents > D018697 - Nootropic Agents
Meptazinol
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists D002491 - Central Nervous System Agents > D000700 - Analgesics N - Nervous system > N02 - Analgesics > N02A - Opioids
Cimbuterol
C13H19N3O (233.15280439999998)
Cimbuterol is a β-adrenergic receptor agonist[1].
metolachlor morpholinone
A member of the class of morpholines that is morpholin-3-one substituted by a 2-ethyl-6-methylphenyl group at position 4 and a methyl group at position 5. It is a metabolite of metolachlor. CONFIDENCE standard compound; EAWAG_UCHEM_ID 67
Meptazinol
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists D002491 - Central Nervous System Agents > D000700 - Analgesics N - Nervous system > N02 - Analgesics > N02A - Opioids CONFIDENCE standard compound; EAWAG_UCHEM_ID 3290
1,2-Epoxy-2-methyl-4-(N-methyltyraminyl)-3-butene|4-(2-N-methyltyraminyl)-(Z)-1,2-epoxy-2-methylbut-3-ene
Me glycoside,N-Ac,4-mesyl-beta-D-Pyranose-3-Amino-3,6-dideoxygalactose
2,4,6-Decatrienoic acid dehydropiperidide-6,7-Dihydro|deca-2E,4E-dienoic piperideide|deca-2t,4t-dienoic-2,3-dehydropiperideide
(4R)-4-(2-isocyano-6-methylhept-5-en-2-yl)-1-methylcyclohexene|7-isocyano-7,8-dihydro-alpha-bisabolene|7-isocyano-7,8-dihydro-alphabisabolene
(1S,2R,3R,5S,6R,8R)-2-isocyanato-5-isopropyl-2,8-dimethyltricyclo[4,3,1,o(3,8)]decane|2-isocyanotrachyopsane
5-(hept-4,6-dienyl)-8-methylindolizidine|Dendrobates Alkaloid 233D
(-)-10-isocyano-4-cadinene|(1R,4S,4aR,8aR)-1,2,3,4,4a,7,8,8a-octahydro-1-isocyano-4-isopropyl-1,6-dimethylnaphthalene|(1R,6R,7S,10R)-10-isocyano-4-cadinene|10-isocyano-4-cadinene
(3E,5E,10Z,13Z)-hexadeca-3,5,10,13-tetraene-2R-amine
(4E,6E)-N-isobutyl-4,6-undecadien-10-ynamide|decumbine
N-[2-(4-Methoxyphenyl)ethyl]-3-methylbut-2-enamide
Et glycoside,N-Ac-alpha-D-Pyranose-2-Amino-2,3-dideoxy-ribo-hexopyranose
11,11-dimethyl-4,8-dimethylene-5-bicyclo[7.2.0]undecanone oxime
Metolachlor-Morpholinone
CONFIDENCE standard compound; INTERNAL_ID 2059
Ritalin
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics > N06BA - Centrally acting sympathomimetics D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators
(5R)-5-methyl-6-((Z)-1,2,3,8a-tetrahydroindolizin-6(5H)-ylidene)hexan-2-one
(2R,5S)-2-allyl-5-((E)-but-2-en-1-yl)decahydroquinoline
(5R,8R)-5-((E)-hepta-4,6-dien-1-yl)-8-methyloctahydroindolizine
(5R,8R)-5-(hept-6-yn-1-yl)-8-methyloctahydroindolizine
5-(hept-6-en-1-yl)-8-methyl-1,2,3,5,8,8a-hexahydroindolizine
5-(but-3-en-1-yl)-8-butyl-1,2,3,5,8,8a-hexahydroindolizine
(5R,6R,8R)-5-(hex-5-yn-1-yl)-6,8-dimethyloctahydroindolizine
(1R,4R)-1-ethyl-4-(pent-4-yn-1-yl)octahydro-2H-quinolizine
Hypusine
An L-lysine derivative that is L-lysine bearing a (2R)-4-amino-2-hydroxybutyl substituent at position N(6).
Dexmethylphenidate
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics > N06BA - Centrally acting sympathomimetics D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators
Lys-ser
C9H19N3O4 (233.13754939999998)
A dipeptide formed from L-lysine and L-serine residues.
Ser-lys
C9H19N3O4 (233.13754939999998)
A dipeptide composed of L-serine and L-lysine joined by a peptide linkage. It is a constituent of bacterial cell wall peptidoglycan type A11.14 and A3alpha.
(4aS,11bS)-9-methoxy-2,3,4,4a,5,6,7,11b-octahydrobenzo[1,2]cyclohepta[4,6-c][1,4]oxazine
2-Amino-4-methylphenylboronic acid, pinacol ester
C13H20BNO2 (233.15870100000004)
2-(2,2-DIMETHYL-4-PHENYL-TETRAHYDRO-PYRAN-4-YL)-ETHYLAMINE
N-(4-aminophenyl)-2-piperidin-1-ylacetamide
C13H19N3O (233.15280439999998)
1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid t-butyl ester
(S)-METHYL 2-((TERT-BUTOXYCARBONYL)AMINO)-3-METHOXYPROPANOATE
5-TERT-BUTYL-2-(2-FLUORO-PHENYL)-2H-PYRAZOL-3-YLAMINE
C13H16FN3 (233.13281879999997)
3-Methyl-1-(phenylmethyl)-3-pyrrolidinecarboxylic acid methyl ester
methyl (2S)-4-hydroxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoate
7-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
N-(1-methylpiperidin-4-yl)benzohydrazide
C13H19N3O (233.15280439999998)
N-benzyl-4-methylpiperazine-1-carboxamide
C13H19N3O (233.15280439999998)
4-(N-Methylamino)phenylboronic acid pinacol ester
C13H20BNO2 (233.15870100000004)
1H-INDAZOLE, 6-FLUORO-3-(1-METHYL-4-PIPERIDINYL)-
C13H16FN3 (233.13281879999997)
2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine
C13H20BNO2 (233.15870100000004)
1,3-Benzodioxole-5-methanamine,N-cyclohexyl-, hydrochloride (1:1)
6-Ethylpyridine-3-boronic acid pinacol ester
C13H20BNO2 (233.15870100000004)
(4-AMINO-BIPHENYL-4-YL)-CARBAMICACIDTERT-BUTYLESTER
C13H19N3O (233.15280439999998)
2,5-Dimethylpyridine-3-boronic acid pinacol ester
C13H20BNO2 (233.15870100000004)
1-[(3-methylphenyl)methyl]piperidine-4-carboxylic acid
6-[2-(dimethylamino)ethoxy]-3,4-dihydro-2H-naphthalen-1-one
2-(2,2,4,7-tetramethyl-1,2,3,4-tetrahydroquinolin-1-yl)ethan-1-ol
2,2,5,5-tetramethyl-4-phenyl-3-imidazoline-3-oxide-1-oxyl
C13H17N2O2 (233.12899620000002)
(R)-ETHYL 2-((TERT-BUTOXYCARBONYL)AMINO)-3-HYDROXYPROPANOATE
4-Amino-2-methylphenylboronic acid, pinacol ester
C13H20BNO2 (233.15870100000004)
1-benzylpiperidine-4-carbohydrazide
C13H19N3O (233.15280439999998)
N-(4-amino-2-methylphenyl)-2-pyrrolidin-1-ylacetamide
C13H19N3O (233.15280439999998)
2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
C13H20BNO2 (233.15870100000004)
3,5-Dimethylpyridine-4-boronic acid pinacol ester
C13H20BNO2 (233.15870100000004)
2-Nitro-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalene
Piperoxan
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
N-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
C13H20BNO2 (233.15870100000004)
3-(TERT-BUTYL)-1-(3-FLUOROPHENYL)-1H-PYRAZOL-5-AMINE
C13H16FN3 (233.13281879999997)
(2R,3S)-1,1-Dimethyl-2-(3-oxobutyl)-3-(3-cyano-1-methylenepropyl) cyclobutane
(2S)-2-(N-tert-Butoxycarbonyl)amino-3-hydroxy-3-methylbutanoic acid
2,6-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
C13H20BNO2 (233.15870100000004)
propyphenazone-d3 (2-n-methyl-d3)
C14H15D3N2O (233.16073733399998)
N-Benzyl-4-aminopiperidine-4-carboxamide
C13H19N3O (233.15280439999998)
1-(4-hydroxy-3-piperidin-1-ylmethyl-phenyl)-ethanone
2-(4-HYDROXY-PIPERIDIN-1-YLMETHYL)-BENZAMIDINE
C13H19N3O (233.15280439999998)
1-BENZOYL-4-(2-AMINOETHYL)PIPERAZINE
C13H19N3O (233.15280439999998)
(4-(1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL)METHANAMINE
2,3-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
C13H20BNO2 (233.15870100000004)
5-fluoro-1-methyl-3-piperidin-4-ylindazole
C13H16FN3 (233.13281879999997)
(1R,5S,9r)-7-benzyl-3-oxa-7-azabicyclo[3.3.1]nonan-9-ol
1-(1-PYRROLIDINYLCARBONYLMETHYL)PIPERAZINEHYDROCHLORIDE
Benzoic acid, 3-(1-aminocyclopropyl)-, 1,1-dimethylethyl ester
methyl (3R,4R)-1-benzyl-4-methylpyrrolidine-3-carboxylate
1-(4-(AMINOMETHYL)PHENYL)-N,N-DIMETHYLPIPERIDIN-4-AMINE
[trans(trans)]-4-propyl[1,1-bicyclohexyl]-4-carbonitrile
2,6-Dimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
C13H20BNO2 (233.15870100000004)
2-((TERT-BUTOXYCARBONYL)AMINO)-3-HYDROXY-3-METHYLBUTANOIC ACID
hexahydro-3-(3-methoxyphenyl)-1-methyl-2H-azepin-2-one
5-Amino-2-methylphenylboronic acid pinacol ester
C13H20BNO2 (233.15870100000004)
[3-[(4-methyl-1,4-diazepan-1-yl)methyl]phenyl]methanamine
ethyl 3-hydroxy-4,4-dimethoxypiperidine-1-carboxylate
[2-(4-methylpiperazinyl)-1-phenylethyl]methylamine
N,N-Dimethyl-2-(piperazin-1-yl)benzamide oxalate
C13H19N3O (233.15280439999998)
Pyrrolidine, 4-methyl-2-[4-(2-methylpropoxy)phenyl]- (9CI)
4-(4-HYDROXY-PIPERIDIN-1-YLMETHYL)-BENZAMIDINE
C13H19N3O (233.15280439999998)
2-Ethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
C13H20BNO2 (233.15870100000004)
Faxeladol
C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist
1-benzylpiperidine-3-carbohydrazide
C13H19N3O (233.15280439999998)
6-AMINO-5-(TERT-BUTYL)-3,3-DIMETHYLBENZOFURAN-2(3H)-ONE
2-(4-aminophenyl)-1-(4-methylpiperazin-1-yl)ethanone
C13H19N3O (233.15280439999998)
(Z)-but-2-enedioic acid,2-(dimethylamino)-2-methylpropan-1-ol
n-methyl-n-phenyl-2-piperazin-1-ylacetamide
C13H19N3O (233.15280439999998)
3-Amino-4-methylphenylboronic acid pinacol ester
C13H20BNO2 (233.15870100000004)
6-(tert-Butyl)-2,2-dimethyl-2H-benzo[b][1,4]oxazin-3(4H)-one
(3S,4R)-rel-1-Boc-3-fluoro-4-(hydroxyMethyl)piperidine
Methyl N-{[(2-methyl-2-propanyl)oxy]carbonyl}homoserinate
4-methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
C13H20BNO2 (233.15870100000004)
6-fluoro-1-methyl-3-piperidin-4-ylindazole
C13H16FN3 (233.13281879999997)
N,N-diethyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)ethanamine
C13H19N3O (233.15280439999998)
N-METHYL-N-[4-[(4-METHYLPIPERAZIN-1-YL)METHYL]BENZYL]AMINE
3-METHYL-2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL) BENZENAMINE
C13H20BNO2 (233.15870100000004)
1-(3,4-DIMETHYLPHENYLAMINO)CYCLOPENTANECARBOXYLICACID
1-(3,5-DIMETHYLPHENYLAMINO)CYCLOPENTANECARBOXYLICACID
4-aminomethylphenylboronic acid pinacol ester HCL
C13H20BNO2 (233.15870100000004)
3-(4-HYDROXY-PIPERIDIN-1-YLMETHYL)-BENZAMIDINE
C13H19N3O (233.15280439999998)
4-(4-ACETYL-PIPERAZIN-1-YL)-2-METHYLANILINE
C13H19N3O (233.15280439999998)
Hopantenic acid
D002491 - Central Nervous System Agents > D018697 - Nootropic Agents C26170 - Protective Agent > C1509 - Neuroprotective Agent
Daytrana
D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors > D018765 - Dopamine Uptake Inhibitors D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D049990 - Membrane Transport Modulators
L-Lysine, N6-(2-amino-2-carboxyethyl)-
C9H19N3O4 (233.13754939999998)
L-Lysine, N6-(2-amino-2-carboxyethyl)-, (R)-
C9H19N3O4 (233.13754939999998)
Rotundine B
Rotundine C is found in root vegetables. Rotundine C is an alkaloid from the rhizomes of Cyperus rotundus (nutgrass). Alkaloid from the rhizomes of Cyperus rotundus (nutgrass). Rotundine C is found in root vegetables.
2-(2,6-Diaminohexanoylamino)-3-hydroxypropanoic acid
C9H19N3O4 (233.13754939999998)
germacra-1(10),4,11(13)-trien-12-oate
C15H21O2- (233.15414660000002)
Valerenate
C15H21O2- (233.15414660000002)
A monocarboxylic acid anion that is the conjugate base of valerenic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
L-hexahomomethionine
An L-polyhomomethionine in which there are eight methylene groups between the alpha-carbon and sulfur atoms.
1-Deoxypentalenate
C15H21O2- (233.15414660000002)
A monocarboxylic acid anion that is the conjugate base of 1-deoxypentalenic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.
alpha-Ionylideneacetate
C15H21O2- (233.15414660000002)
D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
2-[[(2S)-2,6-diaminohexanoyl]amino]oxypropanoic acid
C9H19N3O4 (233.13754939999998)
5-Methoxy-1-methyl-2-(n-propylamino)tetralin
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists
zealexin A1(1-)
A monocarboxylic acid anion resulting forom the deprotonation of the carboxy group of zealexin A1. The major speciess at pH 7.3.
O-(hydroxypropionyl)carnitine
An O-acylcarnitine in which the acyl group specified is hydroxypropionyl.
O-hydroxypropionyl-L-carnitine
An O-acyl-L-carnitine in which the acyl group specified is hydroxypropionyl in which the position of the hydroxy group is unspecified..
(+)-artemisinate
A monocarboxylic acid anion resulting from the removal of a proton from the carboxy group of (+)-artemisinic acid. The major species at pH 7.3.
L-hexahomomethionine zwitterion
An L-polyhomomethionine zwitterion obtained by transfer of a proton from the carboxy to the amino group of L-hexahomomethionine; major species at pH 7.3.
hexahomomethionine zwitterion
Zwitterionic form of hexahomomethionine.
Fluoroethylnormemantine (hydrochloride)
Fluoroethylnormemantine hydrochloride, a derivative of Memantine, is an antagonist of the N-methyl-D-aspartate (NMDA) receptor. [18F]-Fluoroethylnormemantine hydrochloride can be used as a positron emission tomography (PET) tracer. Fluoroethylnormemantine hydrochloride exhibits anti-amnesic, neuroprotective, antidepressant-like and fear-attenuating effects[1][2][3].
Sinbaglustat
C11H23NO4 (233.16269979999998)
Sinbaglustat (OGT2378) is a dual inhibitor of glucosylceramide synthase (GCS) and non-lysosomal glucosyl ceramidase (GBA2). Sinbaglustat is an orally available N-alkyl iminosugar that crosses the blood-brain barrier. Sinbaglustat can be used for the research of central neurodegenerative diseases associated with lysosomal dysfunctions[1][2].